SEC Form 4 · accession 0000914190-18-000366
Cardiovascular Systems Inc · CSII
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott R. Ward
Officer — CEO and President · Director
Period of report
Aug 28, 2018
Accepted (ET)
Aug 30, 2018 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180145
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2018 | A | 28,005 | $0.00 | A | 306,367 | D | |
| Common StockF2 | Aug 28, 2018 | A | 84,013 | $0.00 | A | 390,380 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 34,297 | 34,297 | D |
Explanation of responses
- F1Restrictions lapse as to 9,335 shares on each of 8/28/19, 8/28/20 and 8/28/21.
- F2Subject to performance-based forfeiture based on the Company's three-year total shareholder return for fiscal years 2019, 2020 and 2021 versus the Company's peer group.
- F3Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of the Company's common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the Reporting Person's board membership.